| MPS | meconium plug syndrome; medial premotor system; Member of the Pharmaceutical Society; microbial prof... |
|---|---|
| ACCA | American College of Cardiovascular Administrators |
| ACV | acute cardiovascular [disease]; acyclovir; assisted controlled ventilation; atrial/carotid/ventricul... |
| ASHCVD | atherosclerotic hypertensive cardiovascular disease |
| CC | calcaneal-cuboid; calcium cyclamate; cardiac catheterization; cardiac contusion; cardiac cycle; card... |
| CATCH | Child and Adolescent Trial for Cardiovascular Health |
|---|---|
| MONICA | MONItoring Trends and Determinants in CArdiovascular Disease |
| MONICA | MONItoring of trends and determinants in CArdiovascular disease |
| PRO-CAM | Prospective Cardiovascular Munster |
| CVD | cardiovascular |
| turpentine poisoning | Poisoning from oil of turpentine; symptoms include haematuria, albuminuria, and coma; the urine may have an odour of violets. Synonym: terebinthinism. (05 Mar 2000) |
|---|---|
| zinc poisoning | <disease> Symptoms of zinc poisoning include chills, fever, headache and vomiting. (11 May 1997) |
| fescue poisoning | Poisoning by a toxic principle in tall fescue grass; mainly a disease of cattle, but sheep are sometimes affected; lameness in the hind feet is first noticed, followed by necrosis of the extremities. Synonym: fescue poisoning. (05 Mar 2000) |
| fluoride poisoning | Gen or unspecified fluoride; prefer /pois with specific fluoride term (12 Dec 1998) |
| food poisoning | The development of gastroenteritis secondary to the consumption of bacteria or their toxic byproducts. Onset of symptoms may occur anywhere from 30 minutes to 12 hours after the ingestion of the tainted foodstuffs. (27 Sep 1997) |
| lead poisoning | <pharmacology> An environment hazard (for example, from lead-containing paint, leaded gasoline,etc) capable of causing brain damage. (25 Jun 1999) |
| lecheguilla poisoning | A plant toxaemia of sheep and goats in western Texas, southeastern New Mexico, and northern Mexico caused by eating Agave lecheguilla; there is liver damage resulting in icterus, sometimes haemoglobinuria, and often death, and photosensitivity with oedema, swelling, and crusting of the face and ears. Synonym: swellhead. (05 Mar 2000) |
| abortifacient agents | Chemical substances that interrupt pregnancy after implantation. (12 Dec 1998) |
| abortifacient agents, non-steroidal | Non-steroidal chemical compounds with abortifacient activity. (12 Dec 1998) |
| abortifacient agents, steroidal | Steroidal compounds with abortifacient activity. (12 Dec 1998) |
| adrenergic agents | Drugs that act on adrenergic receptors or affect the life cycle of adrenergic transmitters. Included here are adrenergic agonists and antagonists and agents that affect the synthesis, storage, uptake, metabolism, or release of adrenergic transmitters. (12 Dec 1998) |
| alkylating agents | Highly reactive chemicals that introduce alkyl radicals into biologically active molecules and thereby prevent their proper functioning. Many are used as antineoplastic agent, but most are very toxic, with carcinogenic, mutagenic, teratogenic, and immunosuppressant actions. They have also been used as components in poison gases. (12 Dec 1998) |
| anti-allergic agents | Agents that are used to treat allergic reactions. most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (12 Dec 1998) |
| anti-anxiety agents | Agents that alleviate anxiety, tension, and neurotic symptoms, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. Some are also effective as anticonvulsants, muscle relaxants, or anaesthesia adjuvants. Adrenergic beta-antagonists are commonly used in the symptomatic treatment of anxiety but are not included here. Substances with a benzodiazepine ring structure widely used to treat anxiety and neuroses. Drugs in this class also generally have sedative or weak hypnotic properties and may be effective as muscle relaxants, anticonvulsants, and anaesthesia adjuvants. (12 Dec 1998) |
| anti-arrhythmia agents | Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibres. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (12 Dec 1998) |